Rankings
Pricing
Log In
Free Trial
US-listed companies
ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
PRQR
Market cap
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
iso4217:EUR
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Revenue
-
-
-
-
1
4
Other income
1
6
2
9
1
1
Research and development costs
31
30
46
38
42
51
General and administrative costs
11
13
13
14
17
19
Total operating costs
42
42
59
52
60
70
Operating result
-40
-36
-57
-42
-57
-65
Finance income
-
-
-
-
616,000
4
Financial expense
-
-
-
-
3
5
Results related to associates
-
-
-
-
-0
-0
Gain on disposal of associate
-
-
-
-
514,000
-
Gain (Losses) On Derecognition of Financial Liabilities
-
-
-
-
-
-1
Gains (losses) on financial liabilities at fair value through profit or loss
-
-
-
-0
-2
3
Result before corporate income taxes
-44
-37
-57
-46
-62
-65
Corporate income taxes
0
0
0
0
0
0
Result for the year
-44
-37
-57
-47
-62
-65
Foreign operations - foreign currency translation differences
0
-0
0
-0
1
1
Total comprehensive loss
-
-
-
-
-61
-64
Owners of the Company
-44
-37
-56
-47
-62
-65
Non-controlling interests
-0
-0
-0
-0
-0
0
Result for the year
-44
-37
-57
-47
-62
-65
Owners of the Company
-44
-37
-57
-47
-61
-64
Non-controlling interests
-
-
-
-
-0
0
Total comprehensive loss
-
-
-
-
-61
-64
Basic loss per share
-
-
-
-
-0.96
-0.91
Diluted loss per share
-
-
-
-
-0.96
-0.91